Neuropacs™ Corp., an innovator in AI-enabled neurological imaging, today announced that the U.S. Food and Drug Administration has granted De Novo classification to neuropacs™, a diffusion MRI-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results